Published in Eur J Cancer on August 24, 2011
Long term survival with thoracoscopic versus open lobectomy: propensity matched comparative analysis using SEER-Medicare database. BMJ (2014) 1.81
Socioeconomic inequalities in lung cancer treatment: systematic review and meta-analysis. PLoS Med (2013) 1.31
An evaluation of the impact of large-scale interventions to raise public awareness of a lung cancer symptom. Br J Cancer (2014) 1.29
Bayesian networks for clinical decision support in lung cancer care. PLoS One (2013) 0.98
Lung cancer survival in England: trends in non-small-cell lung cancer survival over the duration of the National Lung Cancer Audit. Br J Cancer (2013) 0.93
Social differences in lung cancer management and survival in South East England: a cohort study. BMJ Open (2012) 0.90
Inequalities in non-small cell lung cancer treatment and mortality. J Epidemiol Community Health (2015) 0.80
[Molecular pathological diagnosis in cytopathology of non-small-cell lung cancer. Standardization of specimen processing]. Pathologe (2013) 0.78
The impact of age at diagnosis on socioeconomic inequalities in adult cancer survival in England. Cancer Epidemiol (2015) 0.75
Appropriate surgical modalities for stages T2a and T2b in the eighth TNM classification of lung cancer. Sci Rep (2017) 0.75
Tea drinking habits and oesophageal cancer in a high risk area in northern Iran: population based case-control study. BMJ (2009) 5.79
Prognostic value of an RNA expression signature derived from cell cycle proliferation genes in patients with prostate cancer: a retrospective study. Lancet Oncol (2011) 4.50
Nomogram incorporating PSA level to predict cancer-specific survival for men with clinically localized prostate cancer managed without curative intent. Cancer (2008) 3.06
Inequalities in outcomes for non-small cell lung cancer: the influence of clinical characteristics and features of the local lung cancer service. Thorax (2011) 2.81
Recent trends in prostate cancer incidence and mortality in southeast England. Eur Urol (2003) 2.59
Highly active antiretroviral therapy and the incidence of non-AIDS-defining cancers in people with HIV infection. J Clin Oncol (2008) 2.38
Incidence trends of adenocarcinoma of the cervix in 13 European countries. Cancer Epidemiol Biomarkers Prev (2005) 2.24
National comparisons of lung cancer survival in England, Norway and Sweden 2001-2004: differences occur early in follow-up. Thorax (2010) 2.21
Lung cancer survival and stage at diagnosis in Australia, Canada, Denmark, Norway, Sweden and the UK: a population-based study, 2004-2007. Thorax (2013) 2.19
Trends in cervical squamous cell carcinoma incidence in 13 European countries: changing risk and the effects of screening. Cancer Epidemiol Biomarkers Prev (2005) 2.03
Variation in incidence of breast, lung and cervical cancer and malignant melanoma of skin by socioeconomic group in England. BMC Cancer (2008) 1.89
Trends in testicular cancer incidence and mortality in 22 European countries: continuing increases in incidence and declines in mortality. Int J Cancer (2006) 1.78
Socio-economic status and oesophageal cancer: results from a population-based case-control study in a high-risk area. Int J Epidemiol (2009) 1.77
Do testicular seminoma and nonseminoma share the same etiology? Evidence from an age-period-cohort analysis of incidence trends in eight European countries. Cancer Epidemiol Biomarkers Prev (2006) 1.75
Breast cancer survival in England, Norway and Sweden: a population-based comparison. Int J Cancer (2010) 1.74
A population-based comparison of the survival of patients with colorectal cancer in England, Norway and Sweden between 1996 and 2004. Gut (2011) 1.70
Cancer survival is dependent on season of diagnosis and sunlight exposure. Int J Cancer (2006) 1.64
SOX9 elevation in the prostate promotes proliferation and cooperates with PTEN loss to drive tumor formation. Cancer Res (2010) 1.64
Local progression among men with conservatively treated localized prostate cancer: results from the Transatlantic Prostate Group. Eur Urol (2007) 1.60
Knowledge of lung cancer symptoms and risk factors in the U.K.: development of a measure and results from a population-based survey. Thorax (2012) 1.53
Using funnel plots to explore variation in cancer mortality across primary care trusts in South-East England. J Public Health (Oxf) (2008) 1.48
Breast carcinoma survival in Europe and the United States. Cancer (2004) 1.43
Interpreting international comparisons of cancer survival: the effects of incomplete registration and the presence of death certificate only cases on survival estimates. Eur J Cancer (2007) 1.43
Trends in incidence of small cell lung cancer and all lung cancer. Lung Cancer (2011) 1.38
The epidemiology and survival of extrapulmonary small cell carcinoma in South East England, 1970-2004. BMC Cancer (2009) 1.35
Estimating attendance for breast cancer screening in ethnic groups in London. BMC Public Health (2010) 1.35
Ethnicity coding in a regional cancer registry and in Hospital Episode Statistics. BMC Public Health (2006) 1.33
Levels of acute health service use among cancer survivors in the United Kingdom. Eur J Cancer (2011) 1.32
High procedure volume is strongly associated with improved survival after lung cancer surgery. J Clin Oncol (2013) 1.31
Availability and structure of primary medical care services and population health and health care indicators in England. BMC Health Serv Res (2004) 1.30
Hospital volume, proportion resected and mortality from oesophageal and gastric cancer: a population-based study in England, 2004-2008. Gut (2012) 1.29
Interpreting the international trends in testicular seminoma and nonseminoma incidence. Nat Clin Pract Urol (2006) 1.29
Oesophageal cancer in Golestan Province, a high-incidence area in northern Iran - a review. Eur J Cancer (2009) 1.27
Colorectal cancer survival in socioeconomic groups in England: variation is mainly in the short term after diagnosis. Eur J Cancer (2011) 1.27
Increased cardiovascular mortality more than fifteen years after radiotherapy for breast cancer: a population-based study. BMC Cancer (2007) 1.23
The incidence and outcome of myeloid malignancies in 2,112 adult patients in southeast England. Haematologica (2006) 1.23
Cessation of alcohol drinking, tobacco smoking and the reversal of head and neck cancer risk. Int J Epidemiol (2009) 1.22
Major shifts in the treatment and prognosis of prostate cancer due to changes in pathological diagnosis and grading. BJU Int (2007) 1.21
Surrogate endpoints for cancer screening trials: general principles and an illustration using the UK Flexible Sigmoidoscopy Screening Trial. J Med Screen (2007) 1.21
Incidence and survival of oesophageal and gastric cancer in England between 1998 and 2007, a population-based study. BMC Cancer (2012) 1.19
A systematic review of barriers to early presentation and diagnosis with breast cancer among black women. BMJ Open (2014) 1.16
The effect of mammographic screening and hormone replacement therapy use on breast cancer incidence in England and Wales. Cancer Epidemiol Biomarkers Prev (2007) 1.15
Lung cancer in England: information from the National Lung Cancer Audit (LUCADA). Lung Cancer (2010) 1.15
Prostate cancer incidence, stage at diagnosis, treatment and survival in ethnic groups in South-East England. BJU Int (2009) 1.14
Colorectal cancer incidence, mortality and survival in South-east England between 1972 and 2001. Eur J Cancer Prev (2007) 1.12
Persistence of bone marrow micrometastases in patients receiving adjuvant therapy for breast cancer: results at 4 years. Int J Cancer (2005) 1.11
Recent trends in resection rates among non-small cell lung cancer patients in England. Thorax (2012) 1.06
Explaining inequalities in access to treatment in lung cancer. J Eval Clin Pract (2006) 1.06
p53 immunochemistry is an independent prognostic marker for outcome in conservatively treated prostate cancer. BJU Int (2009) 1.06
Mortality in relation to early retirement in Denmark: a population-based study. Scand J Public Health (2002) 1.06
Cancer and laterality: a study of the five major paired organs (UK). Cancer Causes Control (2006) 1.05
A cohort study on mental disorders, stage of cancer at diagnosis and subsequent survival. BMJ Open (2014) 1.05
Colorectal cancer survival in the Nordic countries and the United Kingdom: excess mortality risk analysis of 5 year relative period survival in the period 1999 to 2000. Int J Cancer (2007) 1.05
Salvage laryngectomy and pharyngocutaneous fistulae after primary radiotherapy for head and neck cancer: a national survey from DAHANCA. Head Neck (2003) 1.04
Recent changes in lung cancer incidence for south Asians: a population based register study. BMJ (2003) 1.03
Incidence and survival for hepatic, pancreatic and biliary cancers in England between 1998 and 2007. Cancer Epidemiol (2012) 1.03
Quantifying differences in breast cancer survival between England and Norway. Cancer Epidemiol (2011) 1.02
International comparisons of survival from lung cancer: pitfalls and warnings. Nat Clin Pract Oncol (2007) 1.01
The effect of comorbidity on stage-specific survival in resected non-small cell lung cancer patients. Eur J Cancer (2012) 1.01
Histological subtype of lung cancer in relation to socio-economic deprivation in South East England. BMC Cancer (2008) 1.00
Pulmonary metastasectomy for sarcoma: a systematic review of reported outcomes in the context of Thames Cancer Registry data. BMJ Open (2012) 0.97
Inequalities in the incidence of cervical cancer in South East England 2001-2005: an investigation of population risk factors. BMC Public Health (2009) 0.97
The effect of different comorbidities on survival of non-small cells lung cancer patients. Lung (2014) 0.95
Risk factors for metachronous contralateral breast cancer suggest two aetiological pathways. Eur J Cancer (2011) 0.95
Trends in testicular cancer incidence in the Nordic countries, focusing on the recent decrease in Denmark. Int J Androl (2005) 0.95
Prognosis of metachronous contralateral breast cancer: importance of stage, age and interval time between the two diagnoses. Breast Cancer Res Treat (2011) 0.94
Tumor stage affects risk and prognosis of contralateral breast cancer: results from a large Swedish-population-based study. J Clin Oncol (2012) 0.94
Differences in breast cancer hormone receptor status in ethnic groups: a London population. Eur J Cancer (2012) 0.93
Does place of death from cancer vary between ethnic groups in South East England? Palliat Med (2011) 0.93
Lung cancer incidence and survival in England: an analysis by socioeconomic deprivation and urbanization. J Thorac Oncol (2011) 0.93
Hospital volume and survival in oesophagectomy and gastrectomy for cancer. Eur J Cancer (2011) 0.92
Dietary fat and risk of colon and rectal cancer with aberrant MLH1 expression, APC or KRAS genes. Cancer Causes Control (2007) 0.92
Variation in general practice prostate-specific antigen testing and prostate cancer outcomes: an ecological study. Int J Cancer (2014) 0.92
Trends in the treatment of breast cancer in Southeast England following the introduction of national guidelines. J Public Health (Oxf) (2006) 0.92
Socioeconomic and ethnic inequalities in screen-detected breast cancer in London. J Public Health (Oxf) (2013) 0.91